Enzypep designs and develops oligopeptides for pharmaceutical products.
Enzypep designs and develops oligopeptides for pharmaceutical products. The Enzypep technology is expected to become the state-of-the-art in design and preparation of complex peptides. Compared with standard synthesis it results in pharmaceutical products with a much higher purity, at a much lower cost and in a sustainable, environmentally-friendly manner. It began operation in 2012, with its headquarters in Geleen in the Netherlands.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 1, 2014 | Funding Round | — | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Nedermaas Hightech Ventures | — | Funding Round |
Limburg Ventures | — | Funding Round |